Literature DB >> 21729743

Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration.

Yin-Meng Tsai1, Chao-Feng Chien, Lie-Chwen Lin, Tung-Hu Tsai.   

Abstract

Curcumin has considerable neuro-protective and anti-cancer properties but is rapidly eliminated from the body. By optimizing the HPLC method for analysis of curcumin, this study evaluates how the ability of curcumin to penetrate organs and different regions of the brain is affected by nanoparticulation to increase curcumin circulation time in the body. Curcumin-loaded PLGA nanoparticles (C-NPs) were prepared by the high-pressure emulsification-solvent evaporation method. The mean particle size and entrapment efficiency were 163nm and 46.9%, respectively. The release profile of C-NPs was an initial burst effect followed by sustained diffusion. In distribution studies, curcumin could be detected in the evaluated organs, including liver, heart, spleen, lung, kidney and brain. C-NPs were found mainly in the spleen, followed by the lung. Formulation significantly raised the curcumin concentration in these organs with increases in the AUC, t(1/2) and MRT of curcumin, though this was not apparent in the heart. Curcumin and C-NPs could cross the blood-brain barrier (BBB) to enter brain tissue, where it was concentrated chiefly in the hippocampus. Nanoparticulation significantly prolonged retention time of curcumin in the cerebral cortex (increased by 96%) and hippocampus (increased by 83%). These findings provide further understanding for the possible therapeutic effects of curcumin and C-NPs in further pre-clinical and clinical research.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21729743     DOI: 10.1016/j.ijpharm.2011.06.030

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  106 in total

Review 1.  Curcumin nanoformulations: a future nanomedicine for cancer.

Authors:  Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Drug Discov Today       Date:  2011-09-18       Impact factor: 7.851

Review 2.  Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.

Authors:  I M Carvalho; P B Coelho; P C Costa; C S Marques; R S Oliveira; D C Ferreira
Journal:  Neuromolecular Med       Date:  2015-09-15       Impact factor: 3.843

Review 3.  Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles.

Authors:  Francesca Pistollato; Susanne Bremer-Hoffmann; Giuseppe Basso; Sandra Sumalla Cano; Iñaki Elio; Manuel Masias Vergara; Francesca Giampieri; Maurizio Battino
Journal:  Target Oncol       Date:  2016-02       Impact factor: 4.493

4.  Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotection.

Authors:  Bapurao Surnar; Uttara Basu; Bhabatosh Banik; Anis Ahmad; Brian Marples; Nagesh Kolishetti; Shanta Dhar
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-10       Impact factor: 11.205

5.  Synergetic effect of SLN-curcumin and LDH-5-Fu on SMMC-7721 liver cancer cell line.

Authors:  Rongrong Zhu; Xianzheng Wu; Yu Xiao; Bo Gao; Qian Xie; Hui Liu; Shilong Wang
Journal:  Cancer Biother Radiopharm       Date:  2013-06-29       Impact factor: 3.099

Review 6.  Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.

Authors:  Shu Wang; Rui Su; Shufang Nie; Ming Sun; Jia Zhang; Dayong Wu; Naima Moustaid-Moussa
Journal:  J Nutr Biochem       Date:  2013-11-05       Impact factor: 6.048

Review 7.  Epigenetic impact of curcumin on stroke prevention.

Authors:  Anuradha Kalani; Pradip K Kamat; Komal Kalani; Neetu Tyagi
Journal:  Metab Brain Dis       Date:  2014-05-01       Impact factor: 3.584

8.  Conjugated Linoleic Acid-Curcumin Attenuates Cognitive Deficits and Oxidative Stress Parameters in the Ethidium Bromide-Induced Model of Demyelination.

Authors:  Behnaz Barzegarzadeh; Homeira Hatami; Gholamreza Dehghan; Nazli Khajehnasiri; Mehdi Khoobi; Reihaneh Sadeghian
Journal:  Neurotox Res       Date:  2021-03-13       Impact factor: 3.911

9.  Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 mice.

Authors:  Kwok Kin Cheng; Chin Fung Yeung; Shuk Wai Ho; Shing Fung Chow; Albert H L Chow; Larry Baum
Journal:  AAPS J       Date:  2012-12-11       Impact factor: 4.009

10.  Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats.

Authors:  Peng Zou; Lawrence Helson; Anirban Maitra; Stephan T Stern; Scott E McNeil
Journal:  Mol Pharm       Date:  2013-04-22       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.